(LESL) Leslies - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5270641096

LESL: Pool, Spa, Chemicals, Equipment, Cleaning, Maintenance, Services

Leslies, Inc. is a leading direct-to-consumer brand specializing in pool and spa care, operating exclusively in the United States. The company offers a comprehensive range of products and services tailored to pool and spa maintenance, including chemicals, equipment, parts, and cleaning accessories. Additionally, it provides safety, recreational, and fitness-related products. Leslies also delivers installation and repair services for pool and spa equipment, enhancing its value proposition. The company distributes its products through physical stores, e-commerce platforms, and third-party marketplaces, ensuring widespread accessibility. Complimentary in-store water testing and analysis services are available, catering to residential, professional, and commercial customers. Founded in 1963 and headquartered in Phoenix, Arizona, Leslies has established itself as a trusted name in the pool and spa care industry. Web URL: https://lesliespool.com

Ticker Symbol: LESL | Exchange: NASDAQ | Type: Common Stock | Country Origin: United States | GICS Sub Industry: Other Specialty Retail

Based on the provided and , the 3-month forecast for Leslies, Inc. (NASDAQ:LESL) indicates potential volatility and challenges. The stock is currently trading at $1.04, below its SMA20 ($1.61) and SMA50 ($1.96), suggesting downward momentum. The SMA200 ($3.03) further emphasizes the stocks decline over the past year. With an ATR of 0.14, moderate price fluctuations are expected. On the fundamental side, the companys market cap of $269.51M and P/S ratio of 0.20 suggest undervaluation, while the RoE of 12.90% indicates positive returns on equity. However, the absence of P/E and P/B metrics raises concerns about profitability and asset valuation. Over the next three months, the stock may face resistance at its SMA20 and SMA50 levels, with potential downside risks if it fails to recover above these thresholds. Investors should monitor the companys ability to improve its financial performance and navigate market challenges.

Additional Sources for LESL Stock

LESL Stock Overview

Market Cap in USD 193m
Sector Consumer Cyclical
Industry Specialty Retail
GiC Sub-Industry Other Specialty Retail
IPO / Inception 2020-10-29

LESL Stock Ratings

Growth 5y -93.3%
Fundamental -4.21%
Dividend 0.0%
Rel. Strength Industry -89.7
Analysts 3.17/5
Fair Price Momentum 0.50 USD
Fair Price DCF 4.13 USD

LESL Dividends

No Dividends Paid

LESL Growth Ratios

Growth Correlation 3m -90.1%
Growth Correlation 12m -94.1%
Growth Correlation 5y -97.1%
CAGR 5y -53.14%
CAGR/Max DD 5y -0.55
Sharpe Ratio 12m -1.31
Alpha -96.74
Beta 0.89
Volatility 84.26%
Current Volume 6360k
Average Volume 20d 7509.4k
What is the price of LESL stocks?
As of March 14, 2025, the stock is trading at USD 0.79 with a total of 6,359,975 shares traded.
Over the past week, the price has changed by -20.90%, over one month by -50.31%, over three months by -67.62% and over the past year by -88.95%.
Is Leslies a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Leslies is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.21 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LESL as of March 2025 is 0.50. This means that LESL is currently overvalued and has a potential downside of -36.71%.
Is LESL a buy, sell or hold?
Leslies has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold LESL.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 9
  • Sell: 0
  • Strong Sell: 1
What are the forecast for LESL stock price target?
According to ValueRays Forecast Model, LESL Leslies will be worth about 0.5 in March 2026. The stock is currently trading at 0.79. This means that the stock has a potential downside of -31.65%.
Issuer Forecast Upside
Wallstreet Target Price 2.5 212.7%
Analysts Target Price 3.3 312.7%
ValueRay Target Price 0.5 -31.6%